Blockchain is the digital ledger technology that is sweeping through a number of industries on a wave of hype.
The UK’s National Health Service (NHS) has been urged to embrace full automation, including bedside robots and AI diagnoses, to free up frontline staff time worth up to £12.5bn a year – almost 10% of its annual running cost.
Surgery, radiation therapy and chemotherapy have long been the go-to for cancer treatment.
The early and accurate diagnosis of autism spectrum disorder (ASD) in children is crucial.
In the US, organs are in such high demand that 20 people die every day waiting for a transplant.
Japan’s Takeda Pharmaceutical this week agreed to buy Ireland’s Shire for $65 billion.
Japan’s Takeda has agreed to buy Dublin-based Shire Pharmaceuticals for £46 billion ($64.42 billion), in what is the sector’s biggest deal since 2000.
Swiss pharmaceuticals giant Novartis is buying US gene therapy pioneers AveXis for $8.7 billion, in a bid to boost its leadership in neuroscience treatment.
Scientists have predicted that the next flu pandemic to hit the UK could kill as many as 886,000 people and infect 43 million — about three-quarters of the entire population.
A major study into haemotopoietic stem cell transplantation treatment for Multiple Sclerosis has found that it is “stunningly” better than drug treatments, according to one of the doctors involved.
Jennifer Doudna, inventor of revolutionary gene editing technique Crispr, expects the technology to transform agriculture and medicine.
Tributes from tech leaders, scientists, and business people have poured in for world renowned theorist and cosmologist Stephen Hawking after he died in his Cambridge home last night.
A scientific study into cannabis strength revealed high-potency varieties of the drug were more dominant in the UK in 2016 than eight or thirteen years previously.
Apple — the maker of the iPhone and world’s most valuable company — is preparing to take its much anticipated step into the healthcare market with the launch of employee wellness centres.
Canopy Growth Corp, a leading medical marijuana producer, is hoping to change the face of pharmaceuticals as the world begins to relax its laws on cannabis use.
The life expectancy gap between England’s rich and poor has widened, according to a new report.
The number of companies using artificial intelligence in healthcare has increased from less than 20 in 2012 to 100 last year, according to GlobalData Healthcare estimates.
Medopad — the UK-based healthcare tech startup which last week signed £100m worth of projects and partnerships with a number of Chinese companies — said it plans to replicate that success in other countries around the world.
Google-owned artificial intelligence company DeepMind claims to have trained an algorithm to spot signs of eye disease more effectively than human specialists.
Billionaire philanthropist and Microsoft founder Bill Gates had some encouraging words for the World Economic Forum (WEF) in Davos today.
The number of medical drugs launched per $1bn of biotech research and development spending has fallen to just 1/30th of what they were 40 years ago, according to a report out today by the British BioIndustry Association and a UK government-backed innovation centre called the Medicines Discovery Catapult.
A recent UK study has revealed major advances in the treatment of the life-threatening condition haemophilia, leading scientists to anticipate the development of a cure.
Emails released this week under freedom of information rules show that the US Defense Advanced Research Projects Agency (Darpa) is investing $100 million in gene drive technology in a bid to deplete numbers of malaria-carrying mosquitos and other pests.
It is likely that you know of someone who has suffered or is suffering from dementia.
Scientists are starting two studies in Africa trialling a new HIV vaccine and a long-acting injectable drug, fuelling hopes that an effective protection against the virus will soon be developed.
The number of people in Europe newly diagnosed with HIV reached its highest recorded level in 2016, with 160,000 people discovered to have the disease, according to the World Health Organisation (WHO) in collaboration with the European Center for Disease Prevention and Control (ECDC).
The Canadian pharmaceutical giant Concordia has been accused of using its market dominance to make the UK’s National Health Service pay millions of pounds above market value for its thyroid drug.
This week US regulators approved a pill that can track whether patients have taken their medication – the first of its kind.
Have you ever donated blood?
Modern medicine is increasingly reliant on new technology to develop more efficient and less invasive healthcare.